{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:27:33Z","timestamp":1793672853988,"version":"4.5.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["D73C22002140007"],"award-info":[{"award-number":["D73C22002140007"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Positron emission tomography (PET) tracers targeting amyloid-\u03b2 (A\u03b2) are central to the diagnosis and staging of Alzheimer's disease (AD). However, growing evidence indicates that these tracers can engage off-target molecules, complicating signal interpretation. Sulfotransferases (SULTs) have been experimentally identified as binding partners of 11C-Pittsburgh Compound-B (PiB), but whether the clinically used fluorinated PiB derivatives interact with brain-expressed SULTs has not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess whether PiB and its fluorinated derivatives flutemetamol and flutafuranol interact with the SULT isoforms expressed in the human brain, and to characterize the structural features of these interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined multi-omic transcriptomic profiling of the Genotype-Tissue Expression (GTEx) project and the Human Protein Atlas with molecular docking and molecular dynamics (MD) simulations to evaluate the structural interactions of SULT\u2013tracer complexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SULT1A1, SULT1A3, and SULT4A1 were identified as the SULT isoforms predominantly expressed in the human brain, and all three are expressed in the cerebellum, the region used as a reference for A\u03b2 PET signal normalization. Docking and MD simulations showed that all three tracers form energetically comparable complexes within the catalytic pockets of these isoforms, but their dynamic stability varied in an enzyme- and tracer-specific manner. PiB and flutemetamol were stably accommodated in SULT1A1, whereas PiB lost its initial pose in SULT4A1. Flutafuranol showed weaker binding to SULT1A1 but formed stable complexes in SULT1A3 and SULT4A1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide a structural framework for off-target interactions between A\u03b2 PET tracers and brain SULTs and suggest that the intracellular enzymatic environment may contribute to variability in A\u03b2 PET signals beyond fibrillar A\u03b2 deposition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09431-4","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:44:54Z","timestamp":1790653494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the off-target interaction of amyloid PET tracers with human brain sulfotransferases"],"prefix":"10.1007","volume":"47","author":[{"given":"Ludovico","family":"Miccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Fullone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Delli Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Tomaiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano L.","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Floresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-4373","authenticated-orcid":false,"given":"Alberto","family":"Granzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"9431_CR1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(25)01812-4","volume":"406","author":"The Lancet","year":"2025","unstructured":"The Lancet (2025) Alzheimer\u2019s disease: are health systems ready? Lancet 406:1313. https:\/\/doi.org\/10.1016\/S0140-6736(25)01812-4","journal-title":"Lancet"},{"key":"9431_CR2","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2174\/1567205014666170203125942","volume":"14","author":"V Mantzavinos","year":"2017","unstructured":"Mantzavinos V, Alexiou A (2017) Biomarkers for Alzheimer\u2019s Disease Diagnosis. Curr Alzheimer Res 14:1149\u20131154. https:\/\/doi.org\/10.2174\/1567205014666170203125942","journal-title":"Curr Alzheimer Res"},{"key":"9431_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-150692","volume":"49","author":"B Dubois","year":"2016","unstructured":"Dubois B, Padovani A, Scheltens P et al (2016) Timely Diagnosis for Alzheimer\u2019s Disease: A Literature Review on Benefits and Challenges. J Alzheimers Dis JAD 49:617\u2013631. https:\/\/doi.org\/10.3233\/JAD-150692","journal-title":"J Alzheimers Dis JAD"},{"key":"9431_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"9431_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.arr.2016.01.005","volume":"30","author":"VL Villemagne","year":"2016","unstructured":"Villemagne VL (2016) Amyloid imaging: Past, present and future perspectives. Ageing Res Rev 30:95\u2013106. https:\/\/doi.org\/10.1016\/j.arr.2016.01.005","journal-title":"Ageing Res Rev"},{"key":"9431_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55:306\u2013319. https:\/\/doi.org\/10.1002\/ana.20009","journal-title":"Ann Neurol"},{"key":"9431_CR7","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP et al (2003) Synthesis and evaluation of 11\u00a0C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46:2740\u20132754. https:\/\/doi.org\/10.1021\/jm030026b","journal-title":"J Med Chem"},{"key":"9431_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A et al (2010) 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68:319\u2013329. https:\/\/doi.org\/10.1002\/ana.22068","journal-title":"Ann Neurol"},{"key":"9431_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2967\/jnumed.111.094029","volume":"53","author":"Z Csel\u00e9nyi","year":"2012","unstructured":"Csel\u00e9nyi Z, J\u00f6nhagen ME, Forsberg A et al (2012) Clinical validation of 18F-AZD4694, an amyloid-\u03b2-specific PET radioligand. J Nucl Med Off Publ Soc Nucl Med 53:415\u2013424. https:\/\/doi.org\/10.2967\/jnumed.111.094029","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"9431_CR10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3233\/JAD-220841","volume":"90","author":"PF H\u00f8ilund-Carlsen","year":"2022","unstructured":"H\u00f8ilund-Carlsen PF, Revheim M-E, Alavi A et al (2022) Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials. J Alzheimers Dis JAD 90:1395\u20131399. https:\/\/doi.org\/10.3233\/JAD-220841","journal-title":"J Alzheimers Dis JAD"},{"key":"9431_CR11","doi-asserted-by":"publisher","unstructured":"H\u00f8ilund-Carlsen PF, Alavi A, Barrio JR et al (2023) Revision of Alzheimer\u2019s diagnostic criteria or relocation of the Potemkin village. Ageing Res Rev 102173. https:\/\/doi.org\/10.1016\/j.arr.2023.102173","DOI":"10.1016\/j.arr.2023.102173"},{"key":"9431_CR12","doi-asserted-by":"publisher","first-page":"48544","DOI":"10.1021\/acsomega.5c06188","volume":"10","author":"A Granzotto","year":"2025","unstructured":"Granzotto A, Fullone R, Miccoli L et al (2025) Potential Off-Target Interaction of the Amyloid PET Imaging Tracer PiB with Acetylcholinesterase. ACS Omega 10:48544\u201348550. https:\/\/doi.org\/10.1021\/acsomega.5c06188","journal-title":"ACS Omega"},{"key":"9431_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2967\/jnumed.108.057984","volume":"50","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti MT, Rowe CC, McLean CA et al (2009) Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias. J Nucl Med 50:198\u2013204. https:\/\/doi.org\/10.2967\/jnumed.108.057984","journal-title":"J Nucl Med"},{"key":"9431_CR14","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1097\/RLU.0b013e318238f25a","volume":"37","author":"H-Y Kim","year":"2012","unstructured":"Kim H-Y, Kim J, Lee J-H (2012) Incidental Finding of Meningioma on C11-PIB PET. Clin Nucl Med 37:e36. https:\/\/doi.org\/10.1097\/RLU.0b013e318238f25a","journal-title":"Clin Nucl Med"},{"key":"9431_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/RLU.0b013e3182817c8f","volume":"38","author":"Y Yamamoto","year":"2013","unstructured":"Yamamoto Y, Maeda Y, Kawai N et al (2013) Unexpected Finding of Cerebral Meningioma on 11\u00a0C-PiB PET. Clin Nucl Med 38:292. https:\/\/doi.org\/10.1097\/RLU.0b013e3182817c8f","journal-title":"Clin Nucl Med"},{"key":"9431_CR16","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/brain\/awm191","volume":"130","author":"A Lockhart","year":"2007","unstructured":"Lockhart A, Lamb JR, Osredkar T et al (2007) PIB is a non-specific imaging marker of amyloid-beta (A\u03b2) peptide-related cerebral amyloidosis. Brain 130:2607\u20132615. https:\/\/doi.org\/10.1093\/brain\/awm191","journal-title":"Brain"},{"key":"9431_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2967\/jnumed.122.263948","volume":"64","author":"S Flores","year":"2023","unstructured":"Flores S, Chen CD, Su Y et al (2023) Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease. J Nucl Med 64:287\u2013293. https:\/\/doi.org\/10.2967\/jnumed.122.263948","journal-title":"J Nucl Med"},{"key":"9431_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/a-2246-5292","volume":"63","author":"N Hipp","year":"2024","unstructured":"Hipp N, Young KL, Apostolova II et al (2024) Increased off-target binding of [18F]florbetaben in the skull of women with reduced skull density. Nukl Nucl Med 63:247\u2013251. https:\/\/doi.org\/10.1055\/a-2246-5292","journal-title":"Nukl Nucl Med"},{"key":"9431_CR19","unstructured":"A Curious Case of Amyloid Scans Going Awry | ALZFORUM. https:\/\/www.alzforum.org\/news\/conference-coverage\/curious-case-amyloid-scans-going-awry. Accessed 27 Mar 2026"},{"key":"9431_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","volume":"90","author":"N Gamage","year":"2006","unstructured":"Gamage N, Barnett A, Hempel N et al (2006) Human Sulfotransferases and Their Role in Chemical Metabolism. Toxicol Sci 90:5\u201322. https:\/\/doi.org\/10.1093\/toxsci\/kfj061","journal-title":"Toxicol Sci"},{"key":"9431_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1124\/dmd.119.089714","volume":"48","author":"M Idris","year":"2020","unstructured":"Idris M, Mitchell DJ, Gordon R et al (2020) Interaction of the Brain-Selective Sulfotransferase SULT4A1 with Other Cytosolic Sulfotransferases: Effects on Protein Expression and Function. Drug Metab Dispos Biol Fate Chem 48:337\u2013344. https:\/\/doi.org\/10.1124\/dmd.119.089714","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"9431_CR22","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1523\/JNEUROSCI.2194-19.2020","volume":"40","author":"L Culotta","year":"2020","unstructured":"Culotta L, Scalmani P, Vinci E et al (2020) SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95\/NMDAR Complex. J Neurosci Off J Soc Neurosci 40:7013\u20137026. https:\/\/doi.org\/10.1523\/JNEUROSCI.2194-19.2020","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"9431_CR23","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1073\/pnas.0914904107","volume":"107","author":"GB Cole","year":"2010","unstructured":"Cole GB, Keum G, Liu J et al (2010) Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates. Proc Natl Acad Sci 107:6222\u20136227. https:\/\/doi.org\/10.1073\/pnas.0914904107","journal-title":"Proc Natl Acad Sci"},{"key":"9431_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1124\/dmd.108.025767","volume":"37","author":"ED Salman","year":"2009","unstructured":"Salman ED, Kadlubar SA, Falany CN (2009) Expression and Localization of Cytosolic Sulfotransferase (SULT) 1A1 and SULT1A3 in Normal Human Brain. Drug Metab Dispos 37:706\u2013709. https:\/\/doi.org\/10.1124\/dmd.108.025767","journal-title":"Drug Metab Dispos"},{"key":"9431_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/JAD-190559","volume":"73","author":"AJ Surmak","year":"2020","unstructured":"Surmak AJ, Wong K-P, Cole GB et al (2020) Probing Estrogen Sulfotransferase-Mediated Inflammation with [11\u00a0C]-PiB in the Living Human Brain. J Alzheimers Dis JAD 73:1023\u20131033. https:\/\/doi.org\/10.3233\/JAD-190559","journal-title":"J Alzheimers Dis JAD"},{"key":"9431_CR26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium (2020) The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369:1318\u20131330. https:\/\/doi.org\/10.1126\/science.aaz1776","journal-title":"Science"},{"key":"9431_CR27","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347:1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"key":"9431_CR28","doi-asserted-by":"publisher","first-page":"RP86933","DOI":"10.7554\/eLife.86933","volume":"12","author":"K Wagstyl","year":"2024","unstructured":"Wagstyl K, Adler S, Seidlitz J et al (2024) Transcriptional cartography integrates multiscale biology of the human cortex. eLife 12:RP86933. https:\/\/doi.org\/10.7554\/eLife.86933","journal-title":"eLife"},{"key":"9431_CR29","unstructured":"(2023) Discovery Studio. In: Dassault Syst\u00e8mes. https:\/\/www.3ds.com\/products\/biovia\/discovery-studio. Accessed 8 Apr 2026"},{"key":"9431_CR30","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1021\/acs.jcim.0c00057","volume":"60","author":"H Guterres","year":"2020","unstructured":"Guterres H, Im W (2020) Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations. J Chem Inf Model 60:2189\u20132198. https:\/\/doi.org\/10.1021\/acs.jcim.0c00057","journal-title":"J Chem Inf Model"},{"key":"9431_CR31","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan K, Grauffel C, Lim C (2017) How Molecular Size Impacts RMSD Applications in Molecular Dynamics Simulations. J Chem Theory Comput 13:1518\u20131524. https:\/\/doi.org\/10.1021\/acs.jctc.7b00028","journal-title":"J Chem Theory Comput"},{"key":"9431_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00008571-200403000-00009","volume":"14","author":"RL Blanchard","year":"2004","unstructured":"Blanchard RL, Freimuth RR, Buck J et al (2004) A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenet Genomics 14:199","journal-title":"Pharmacogenet Genomics"},{"key":"9431_CR33","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1038\/s41467-023-37437-5","volume":"14","author":"L Brase","year":"2023","unstructured":"Brase L, You S-F, D\u2019Oliveira Albanus R et al (2023) Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. Nat Commun 14:2314. https:\/\/doi.org\/10.1038\/s41467-023-37437-5","journal-title":"Nat Commun"},{"key":"9431_CR34","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"CC Rowe","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U et al (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718\u20131725. https:\/\/doi.org\/10.1212\/01.wnl.0000261919.22630.ea","journal-title":"Neurology"},{"key":"9431_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2967\/jnumed.119.235879","volume":"61","author":"E Fantoni","year":"2020","unstructured":"Fantoni E, Collij L, Alves IL et al (2020) The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging. J Nucl Med 61:166\u2013171. https:\/\/doi.org\/10.2967\/jnumed.119.235879","journal-title":"J Nucl Med"},{"key":"9431_CR36","doi-asserted-by":"publisher","unstructured":"Granzotto A, FULLONE R, Miccoli L (2026) Sulfotransferases (SULTs) interaction whit amyloid PET tracers dataset. https:\/\/doi.org\/10.5281\/zenodo.22304099","DOI":"10.5281\/zenodo.22304099"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09431-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:02:28Z","timestamp":1793671348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09431-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9431"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09431-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Large language model\u2013based assistance (Claude Sonnet 4.6 and Opus 4.8, Anthropic) was used exclusively for language polishing and formatting. The authors are fully responsible for the scientific content, interpretation, and conclusions.","order":1,"name":"Ethics","label":"AI statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the manuscript complies with the journal ethical standards. The research does not involve human participants and\/or animals.","order":2,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"819"}}